Genovese, E.; Mirabile, M.; Rontauroli, S.; Sartini, S.; Fantini, S.; Tavernari, L.; Maccaferri, M.; Guglielmelli, P.; Bianchi, E.; Parenti, S.;
et al. The Response to Oxidative Damage Correlates with Driver Mutations and Clinical Outcome in Patients with Myelofibrosis. Antioxidants 2022, 11, 113.
https://doi.org/10.3390/antiox11010113
AMA Style
Genovese E, Mirabile M, Rontauroli S, Sartini S, Fantini S, Tavernari L, Maccaferri M, Guglielmelli P, Bianchi E, Parenti S,
et al. The Response to Oxidative Damage Correlates with Driver Mutations and Clinical Outcome in Patients with Myelofibrosis. Antioxidants. 2022; 11(1):113.
https://doi.org/10.3390/antiox11010113
Chicago/Turabian Style
Genovese, Elena, Margherita Mirabile, Sebastiano Rontauroli, Stefano Sartini, Sebastian Fantini, Lara Tavernari, Monica Maccaferri, Paola Guglielmelli, Elisa Bianchi, Sandra Parenti,
and et al. 2022. "The Response to Oxidative Damage Correlates with Driver Mutations and Clinical Outcome in Patients with Myelofibrosis" Antioxidants 11, no. 1: 113.
https://doi.org/10.3390/antiox11010113
APA Style
Genovese, E., Mirabile, M., Rontauroli, S., Sartini, S., Fantini, S., Tavernari, L., Maccaferri, M., Guglielmelli, P., Bianchi, E., Parenti, S., Carretta, C., Mallia, S., Castellano, S., Colasante, C., Balliu, M., Bartalucci, N., Palmieri, R., Ottone, T., Mora, B.,
... on behalf of the Mynerva (MYeloid NEoplasms Research Venture AIRC).
(2022). The Response to Oxidative Damage Correlates with Driver Mutations and Clinical Outcome in Patients with Myelofibrosis. Antioxidants, 11(1), 113.
https://doi.org/10.3390/antiox11010113
